Influence of a carrier transport process on in vivo release and metabolism of dopamine: Dependence of extracellular Na+
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 45 (4) , 283-293
- https://doi.org/10.1016/0024-3205(89)90137-9
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Scope and limitations of in vivo brain dialysis: A comparison of its application to various neurotransmitter systemsLife Sciences, 1987
- The neuronal noradrenaline transport system of PC-12 cells: Kinetic analysis of the interaction between noradrenaline, Na+ and Cl? in transportNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986
- Pharmacology in vivo of the phenylindan derivative, lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- In Vivo Measurement of Dopamine and Its Metabolites by Intracerebral Dialysis: Changes After d‐AmphetamineJournal of Neurochemistry, 1983
- Evidence for carrier-mediated efflux of dopamine from corpus striatumBiochemical Pharmacology, 1982
- Biochemistry of Neurotransmitter ReleaseAnnual Review of Neuroscience, 1979
- Kinetic analysis of the interaction between noradrenaline and Na+ in neuronal uptake: Kinetic evidence for CO-transportNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Calciumm-dependent release of endogenous serotonin, dopamine and norepinephrine from nerve endingsLife Sciences, 1977
- Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatumJournal of Pharmacy and Pharmacology, 1974
- Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atriaBritish Journal of Pharmacology, 1973